(4,5-二甲基-1H-苯并咪唑-2-基)甲醇 | 915921-59-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 中文名称: (4,5-二甲基-1H-苯并咪唑-2-基)甲醇
• 英文名称: (4,5-dimethyl-1H-benzo[d]imidazol-2-yl)methanol
• 英文别名: (4,5-dimethyl-1H-benzimidazol-2-yl)methanol
• CAS: 915921-59-4
• 化学式: C₁₀H₁₂N₂O
• mdl: MFCD09701677
• 分子量: 176.218
• InChiKey: DXIFJQQSMWQYTC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  48.9
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  (4,5-二甲基-1H-苯并咪唑-2-基)甲醇 在 四丁基溴化铵 、 戴斯-马丁氧化剂 、 potassium hydroxide 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 6.0h， 生成 1,4,5-Trimethylbenzimidazole-2-carbaldehyde
  参考文献：
  名称：

  Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity

  摘要：

  A novel curcumin mimic library (14a-14h and 15a-15h) possessing variously substituted benzimidazole groups was synthesized through the aldol reaction of (E)-4-(4-hydroxy-3-methoxyphenyl)but-3-en-2-one (7) or (E)-4-(3-hydroxy-4-methoxyphenyl)but-3-en-2-one (13) with diversely substituted benzimidazolyl-2-carbaldehyde (12a-12h). The MTT assay of the cancer cells MCF-7, SH-SY5Y, HEP-G2, and H460 showed that compound 14c with IC50 of 1.0 and 1.9 mu M has a strong inhibitory effect on the growth of SH-SY5Y and Hep-G2 cells, respectively, and that compound 15h with IC50 of 1.9 mu M has a strong inhibitory effect on the growth of MCF-7 cancer cells. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.12.074
• 作为产物：
  描述：

  羟基乙酸 、 3,4-二甲基-O-苯二胺 在 盐酸 作用下， 以 水 为溶剂， 反应 6.0h， 生成 (4,5-二甲基-1H-苯并咪唑-2-基)甲醇
  参考文献：
  名称：

  Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity

  摘要：

  A novel curcumin mimic library (14a-14h and 15a-15h) possessing variously substituted benzimidazole groups was synthesized through the aldol reaction of (E)-4-(4-hydroxy-3-methoxyphenyl)but-3-en-2-one (7) or (E)-4-(3-hydroxy-4-methoxyphenyl)but-3-en-2-one (13) with diversely substituted benzimidazolyl-2-carbaldehyde (12a-12h). The MTT assay of the cancer cells MCF-7, SH-SY5Y, HEP-G2, and H460 showed that compound 14c with IC50 of 1.0 and 1.9 mu M has a strong inhibitory effect on the growth of SH-SY5Y and Hep-G2 cells, respectively, and that compound 15h with IC50 of 1.9 mu M has a strong inhibitory effect on the growth of MCF-7 cancer cells. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.12.074

文献信息

• Sustainable Synthesis of 2‐Hydroxymethylbenzimidazoles using D‐Fructose as a C ₂ Synthon
  作者：Dineshkumar Raja、Abigail Philips、Devikala Sundaramurthy、Gopal Chandru Senadi

  DOI：10.1002/asia.202100972

  日期：2021.11.15

  carbohydrate has been identified as an environmentally benign C2 synthon in the preparation of synthetically useful 2-hydroxymethylbenzimidazole derivatives by coupling with 1,2-phenylenediamines. The pivotal features of this method include metal-free conditions, short time, good functional group tolerance, gram scale feasibility and the synthesis of benzimidazole fused 1,4-oxazine.

  D-果糖是一种生物质衍生的碳水化合物，在通过与 1,2-苯二胺偶联制备合成有用的 2-羟甲基苯并咪唑衍生物时，已将其鉴定为环境无害的 C 2合成子。该方法的关键特征包括无金属条件、时间短、官能团耐受性好、克级可行性和苯并咪唑稠合 1,4-恶嗪的合成。
• Heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
  申请人：Daewoong Pharmaceutical Co., Ltd.

  公开号：US10981917B2

  公开（公告）日：2021-04-20

  The present invention relates to a heterocyclic compound represented by Chemical Formula 1 that can be used for the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.

  本发明涉及一种由化学式 1 表示的可用于预防或治疗因 PRS（脯氨酰-tRNA 合成酶）活性异常引起的疾病的杂环化合物或其药学上可接受的盐、制备方法以及包含该化合物的药物组合物。